Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global C-reactive Protein Testing Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017–2031

5. Key Insights
    5.1. Overview of C-reactive Protein Testing Market
    5.2. Key Product/ Brand Analysis
    5.3. Pipeline Analysis
    5.4. COVID-19 Pandemic Impact on Industry

6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Test Type, 2017–2031
        6.3.1. Standard C-reactive Protein Test
        6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    6.4. Market Attractiveness Analysis, by Test Type

7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Type of Assay, 2017–2031
        7.3.1. ELISA
        7.3.2. Immunoturbidimetry
        7.3.3. Immuno-chromatography
        7.3.4. Immunofluorescence
        7.3.5. Others
    7.4. Market Attractiveness Analysis, by Type of Assay

8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Indication, 2017–2031
        8.3.1. Heart Diseases
        8.3.2. Inflammatory Diseases
        8.3.3. Infectious Diseases
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Indication

9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospital Associated Laboratories
        9.3.2. Independent Diagnostic Laboratories
        9.3.3. Others
    9.4. Market Attractiveness Analysis, by End-user

10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017–2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region

11. North America C-reactive Protein Testing Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Test Type, 2017–2031
        11.2.1. Standard C-reactive Protein Test
        11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    11.3. Market Value Forecast, by Type of Assay, 2017–2031
        11.3.1. ELISA
        11.3.2. Immunoturbidimetry
        11.3.3. Immuno-chromatography
        11.3.4. Immunofluorescence
        11.3.5. Others
    11.4. Market Value Forecast, by Indication, 2017–2031
        11.4.1. Heart Diseases
        11.4.2. Inflammatory Diseases
        11.4.3. Infectious Diseases
        11.4.4. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospital Associated Laboratories
        11.5.2. Independent Diagnostic Laboratories
        11.5.3. Others
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Test Type
        11.7.2. By Type of Assay
        11.7.3. By Indication
        11.7.4. By End-user
        11.7.5. By Country

12. Europe C-reactive Protein Testing Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Test Type, 2017–2031
        12.2.1. Standard C-reactive Protein Test
        12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    12.3. Market Value Forecast, by Type of Assay, 2017–2031
        12.3.1. ELISA
        12.3.2. Immunoturbidimetry
        12.3.3. Immuno-chromatography
        12.3.4. Immunofluorescence
        12.3.5. Others
    12.4. Market Value Forecast, by Indication, 2017–2031
        12.4.1. Heart Diseases
        12.4.2. Inflammatory Diseases
        12.4.3. Infectious Diseases
        12.4.4. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospital Associated Laboratories
        12.5.2. Independent Diagnostic Laboratories
        12.5.3. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Test Type
        12.7.2. By Type of Assay
        12.7.3. By Indication
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Test Type, 2017–2031
        13.2.1. Standard C-reactive Protein Test
        13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    13.3. Market Value Forecast, by Type of Assay, 2017–2031
        13.3.1. ELISA
        13.3.2. Immunoturbidimetry
        13.3.3. Immuno-chromatography
        13.3.4. Immunofluorescence
        13.3.5. Others
    13.4. Market Value Forecast, by Indication, 2017–2031
        13.4.1. Heart Diseases
        13.4.2. Inflammatory Diseases
        13.4.3. Infectious Diseases
        13.4.4. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospital Associated Laboratories
        13.5.2. Independent Diagnostic Laboratories
        13.5.3. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Test Type
        13.7.2. By Type of Assay
        13.7.3. By Indication
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America C-reactive Protein Testing Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Test Type, 2017–2031
        14.2.1. Standard C-reactive Protein Test
        14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    14.3. Market Value Forecast, by Type of Assay, 2017–2031
        14.3.1. ELISA
        14.3.2. Immunoturbidimetry
        14.3.3. Immuno-chromatography
        14.3.4. Immunofluorescence
        14.3.5. Others
    14.4. Market Value Forecast, by Indication, 2017–2031
        14.4.1. Heart Diseases
        14.4.2. Inflammatory Diseases
        14.4.3. Infectious Diseases
        14.4.4. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospital Associated Laboratories
        14.5.2. Independent Diagnostic Laboratories
        14.5.3. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Test Type
        14.7.2. By Type of Assay
        14.7.3. By Indication
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Test Type, 2017–2031
        15.2.1. Standard C-reactive Protein Test
        15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    15.3. Market Value Forecast, by Type of Assay, 2017–2031
        15.3.1. ELISA
        15.3.2. Immunoturbidimetry
        15.3.3. Immuno-chromatography
        15.3.4. Immunofluorescence
        15.3.5. Others
    15.4. Market Value Forecast, by Indication, 2017–2031
        15.4.1. Heart Diseases
        15.4.2. Inflammatory Diseases
        15.4.3. Infectious Diseases
        15.4.4. Others
    15.5. Market Value Forecast, by End-user, 2017–2031
        15.5.1. Hospital Associated Laboratories
        15.5.2. Independent Diagnostic Laboratories
        15.5.3. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Test Type
        15.7.2. By Type of Assay
        15.7.3. By Indication
        15.7.4. By End-user
        15.7.5. By Country/Sub-region

16. Competition Landscape
    16.1. Market Player - Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. Agilent Technologies, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Laboratory Corporation of America Holdings
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Thermo Fisher Scientific
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Abbott Laboratories
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. F. Hoffmann-La Roche Ltd.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Creative Diagnostics
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. DxGen Corp
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. CTK Biotech, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Getein Biotech, Inc.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Goldsite Diagnostics, Inc.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. OptiBio Co., Ltd.
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Nanjing Vazyme Biotech Co., Ltd.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global C-reactive Protein Testing Market Value Share, by Test Type, 2022

Figure 03: Global C-reactive Protein Testing Market Value Share, by Types of Assay, 2022

Figure 04: Global C-reactive Protein Testing Market Value Share, by Indication, 2022

Figure 05: Global C-reactive Protein Testing Market Value Share, by End-user, 2022

Figure 06: Global C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 07: Global C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 08: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Standard C-reactive Protein Test , 2017–2031

Figure 09: Global C-reactive Protein Testing Market Revenue (US$ Mn), by High-sensitivity C-reactive Protein (hs-CRP) Test, 2017–2031

Figure 10: Global C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 11: Global C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023–2031

Figure 12: Global C-reactive Protein Testing Market Value (US$ Mn), by ELISA, 2017?2031

Figure 13: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunoturbidimetry, 2017?2031

Figure 14: Global C-reactive Protein Testing Market Value (US$ Mn), by Irreversible Immuno-chromatography, 2017?2031

Figure 15: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunofluorescence, 2017?2031

Figure 16: Global C-reactive Protein Testing Market Value (US$ Mn), by Others, 2017?2031

Figure 17: Global C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 18: Global C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023–2031

Figure 19: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Heart Diseases, 2017–2031

Figure 20: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Inflammatory Diseases, 2017–2031

Figure 21: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031

Figure 22: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017–2031

Figure 23: Global C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 24: Global C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 25: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Hospital Associated Laboratories, 2017–2031

Figure 26: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Independent Diagnostic Laboratories, 2017–2031

Figure 27: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017–2031

Figure 28: Global C-reactive Protein Testing Market Value Share Analysis, by Region, 2022 and 2031

Figure 29: Global C-reactive Protein Testing Market Attractiveness Analysis, by Region, 2023–2031

Figure 30: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 31: North America C-reactive Protein Testing Market Value Share Analysis, by Country, 2022 and 2031

Figure 32: North America C-reactive Protein Testing Market Attractiveness Analysis, by Country, 2023–2031

Figure 33: North America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 34: North America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 35: North America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 36: North America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023–2031

Figure 37: North America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 38: North America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023–2031

Figure 39: North America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 40: North America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 41: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Europe C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 43: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Europe C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 45: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 46: Europe C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 47: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023–2031

Figure 48: Europe C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 49: Europe C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023–2031

Figure 50: Europe C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 51: Europe C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 52: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 53: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 54: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 55: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 56: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 57: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 58: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023–2031

Figure 59: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 60: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023–2031

Figure 61: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 62: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 63: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 64: Latin America C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 65: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 66: Latin America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 67: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 68: Latin America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 69: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023–2031

Figure 70: Latin America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 71: Latin America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023–2031

Figure 72: Latin America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 73: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 74: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 75: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 76: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 77: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031

Figure 78: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 79: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031

Figure 80: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay 2023–2031

Figure 81: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031

Figure 82: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Indication, 2023–2031

Figure 83: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031

Figure 84: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 85: Global C-reactive Protein Testing Market Share Analysis By Company (2022)

List of Tables

List of Tables

Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017?2031

Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031